The reconstitution process seems simple on the surface
Suitable for daily maintenance, gentle and nourishing
You may experience mild tenderness, redness, or slight bruising at the injection site, which typically resolves within a day or two
Earlier Phase 2 monotherapy work also studied higher weekly doses up to 4.5 mg, but the cagrilintide-only schedule above matches the 2.4 mg weekly target shown throughout this page
Expanding access to stigma-free, human-centered treatment options will improve health outcomes for people living with SUD, and exploring new drug classes for treating addiction is a worthwhile venture.
Sustainable, Real-Life Results More patients today are seeking treatments they can realistically maintain in everyday life not only dramatic results, but consistent, manageable care